Troy A. Ignelzi - 02 Feb 2026 Form 4 Insider Report for Rapport Therapeutics, Inc. (RAPP)

Reporting relationship: Chief Financial Officer
Issuer ticker: RAPP
Reported as of: 02 Feb 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 04 Feb 2026, 16:12:21 UTC
Prior SEC filing: 26 Jun 2025
Next SEC filing: 06 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Troy Ignelzi

Key filing fact

Troy A. Ignelzi filed Form 4 for Rapport Therapeutics, Inc. (RAPP) on 04 Feb 2026.

Key facts

This page summarizes Troy A. Ignelzi's Form 4 filing for Rapport Therapeutics, Inc. (RAPP).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 04 Feb 2026, 16:12.

Change

Previous filing in this sequence was filed on 26 Jun 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001579829 Primary reporting owner

Ignelzi Troy A.

Relationship: Chief Financial Officer
Address: RAPPORT THERAPEUTICS, INC., 99 HIGH STREET, SUITE 2100, BOSTON
Signature: /s/ Troy Ignelzi
Signature date: 04 Feb 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RAPP transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +148,000
Change %
Price: $0.000000
Shares after: 148,000
Date: 02 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 148,000
Exercise price: $27.75
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments following January 1, 2026, subject to the Reporting Person's continued service on each such vesting date.